Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid testsNicolas R Barthélemy, Oskar Hansson, Gemma Salvadó et al.|Nature Medicine|2024Cited by 401
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s diseaseKanta Horie, Randall J. Bateman, Gemma Salvadó et al.|Nature Medicine|2023Cited by 249
Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscapeHarald Hampel, Suzanne E. Schindler|Neuron|2023Cited by 235
Biomarker-based staging of Alzheimer disease: rationale and clinical applicationsJoseph Therriault, Pedro Rosa‐Neto, Suzanne E. Schindler et al.|Nature Reviews Neurology|2024Cited by 171
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s diseaseNicolas R. Barthélemy, Suzanne E. Schindler, Benjamin Saef et al.|Nature Aging|2023Cited by 150